Joost M Bakker Selected Research

Neoplasms (Cancer)

2/2011	Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.
9/2002	Reduced tumor growth, experimental metastasis formation, and angiogenesis in rats with a hyperreactive dopaminergic system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joost M Bakker Research Topics

Disease

3	Lung Diseases (Lung Disease) 01/2007 - 12/2002
2	Multiple Myeloma 02/2011 - 02/2011
2	Neoplasms (Cancer) 02/2011 - 09/2002
1	Rupture 01/2023
1	Vascular Diseases (Vascular Disease) 08/2011
1	Lymphoma (Lymphomas) 02/2011
1	Hematologic Neoplasms (Hematological Malignancy) 02/2011
1	Communicable Diseases (Infectious Diseases) 09/2004
1	Hypertrophy 12/2002
1	Adenocarcinoma 09/2002
1	Hypersensitivity (Allergy) 09/2002

Drug/Important Bio-Agent (IBA)

3	GlucocorticoidsIBA 01/2007 - 12/2002
2	Complement System Proteins (Complement)IBA 02/2011 - 02/2011
2	daratumumabIBA 02/2011 - 02/2011
2	Monoclonal AntibodiesIBA 02/2011 - 02/2011
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2007 - 09/2004
1	Oxygen (Dioxygen)IBA 01/2023
1	CarbonIBA 01/2023
1	MetalsIBA 01/2023
1	AntibodiesIBA 08/2011
1	Lenalidomide (CC 5013)FDA Link 02/2011
1	Glycoproteins (Glycoprotein)IBA 02/2011
1	Heterophile AntigensIBA 09/2004
1	CollagenIBA 12/2002
1	Proteins (Proteins, Gene)FDA Link 12/2002
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 09/2002
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2002
1	Hemoglobins (Hemoglobin)IBA 09/2002
1	matrigelIBA 09/2002

Therapy/Procedure

1	Immunotherapy 02/2011